Moffitt Cancer Center Hosts Indo-U.S. Bilateral Workshop On Accelerating Botanicals And Biologics Agent Development Research

March 16, 2012

TAMPA, Fla. – Moffitt Cancer Center and the Center for Development of Advanced Computing in India will present a workshop “Accelerating Botanicals and Biologics Agent Development Research for Cancer Chemoprevention” from May 29-31 at Moffitt, 12902 Magnolia Drive in Tampa.

The workshop, which is funded by the Indo-U.S. Science and Technology Forum, is designed to bring together trans-disciplinary stakeholders from both countries. They include research scientists, clinical oncologists, government funding agencies, regulatory bodies, and biotechnology and bioinformatics professionals interested in botanical and biologic drug development and applications for cancer prevention and treatment.

Speakers and participants from the U.S. will include scientists from Moffitt and other cancer centers – The University of Texas MD Anderson Cancer Center, Memorial Sloan-Kettering Cancer Center, The Ohio State University, Barbara Ann Karmanos Cancer Institute, University of Michigan, University of Kansas and Emory University – as well as the National Cancer Institute, Food and Drug Administration and Open Health Systems Laboratory. Participants and speakers from India will include scientists from the Centre for Development of Advanced Computing, Pune; Tata Memorial Centre, Mumbai; Cancer Foundation of India; Central University of Gujarat; Indian Institute of Technology, Delhi and Chennai.

“It is clear that both countries have their strengths and resources, which when combined can actively facilitate the building of an interdisciplinary community harnessing systems of Information and Communications Technology towards accelerating botanicals and biologic drug development on an international scale for cancer prevention and treatment,” said Nagi Kumar, Ph.D., R.D., F.A.D.A., director of Nutrition Research at Moffitt and co-director of the workshop.

“At the end of the workshop, our goal is to establish Indo-U.S. working collaborative research teams focused on identifying, prioritizing agents – botanicals/ biologics – targeting cancers that are of priority to both countries,” said Medha Dhurandhar, Ph.D., head of the  Centre for Development of Advanced Computing, and co-director of the workshop.

About Moffitt Cancer Center

Follow Moffitt on Facebook:

Follow Moffitt on Twitter: @MoffittNews

Follow Moffitt on YouTube: MoffittNews

Located in Tampa, Moffitt Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center, a description that recognizes Moffitt’s excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt is also a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer.